Fierce Healthcare January 13, 2025
Matthew Gibbs

The pharmaceutical supply chain is a sector infamous for glacially slow adjustments, lackluster reform, lack of transparency and massive anti-competitive conglomerates.

Years of dominance by the three major vertically integrated pharmacy benefit managers that control the bulk of the market have placed great strain on the healthcare industry. However, a recent confluence of events marks the first time in decades that I’ve seen any indication of real, meaningful change to the system.

Signs of progress became impossible to ignore in 2024. The Big Three...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
ASHP to CMS: 'Change course' on drug pricing
Many independent pharmacists will not stock drugs in the price negotiation program
Measuring Progress for Life Sciences: Trust, Patient Access, and Prevention at a Fork in the Road of Public Health
2025 Pharma Forecast: Four Pivotal Trends Revolutionizing Market Access Strategies
Christophe Weber, veteran Takeda CEO, to retire next year

Share This Article